Early Drug Discovery Services: Why Do You Need A CRO?
We discuss the the early drug discovery services market and highlight the integrated drug discovery CRO services provided by SARomics Biostructures.
integrated drug discovery
-
-
DNA-Encoded Library Screening For Drug Discovery
SARomics Biostructures AB and Vipergen ApS partner to offer hit and lead identification services based on Vipergen’s unique DNA-encoded library (DEL) screening technology.
-
WAC™ Fragment screening technology: Principles & Advantages
In this article, we discuss weak affinity chromatography (WAC™), the proprietary fragment screening technique jointly owned by SARomics Biostructures and Red Glead Discovery.
-
TAK1 inhibitor secures € 950 million
Using an integrated drug discovery approach, first-in-class TAK1 kinase inhibitors were designed in a hit-to-lead program run in close cooperation between three partners, SARomics Biostructures, Red Glead Discovery, and Aqilion.
-
How to Choose A Library for Screening?
In this third post on structural biology and structure-based drug design we discuss methods and benefits of fragment-based lead discovery
-
LundaGUARD – A Consortium For Fighting Infectious Agents
Several private and public organizations join efforts in the LundaGUARD consortium to respond to present and future threats from infectious agents.
